ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.

Mafalda Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.